Public defence: Helle Herrman

Cand.med. Helle Herrman at Institute of Clinical Medicine will be defending the thesis “Deep brain stimulation to the anterior thalamic nuclei in refractory epilepsy. A double-blinded, prospective, randomized study on effect and safety” for the degree of PhD (Philosophiae Doctor).

Due to copyright issues, an electronic copy of the thesis must be ordered from the faculty. For the faculty to have time to process the order, the order must be received by the faculty at the latest 2 days before the public defence. Orders received later than 2 days before the defence will not be processed. After the public defence, please address any inquiries regarding the thesis to the candidate.

Order a digital copy of the thesis here

Trial Lecture – time and place

See Trial Lecture.

Adjudication committee

  • First opponent: Professor Anne Sabers, University of Copenhagen, Denmark
  • Second opponent: Associate Professor Geir Bråthen, Norwegian University of Science and Technology, Trondheim
  • Third member and chair of the evaluation committee: Professor II Angelika Sorteberg, University of Oslo

Chair of the Defence

Professor II Bjørnar Hassel, University of Oslo

Principal Supervisor

Professor II Espen Dietrichs, University of Oslo

Summary

Deep brain stimulation in refractory epilepsy in adults

Norway has about 35000 people with epilepsy. Around 30% are not seizure free on drug therapy or after resective neurosurgery. Other treatment options are needed. In deep brain stimulation thin electrodes are implanted and brain activity altered through low current electrical pulses. This is established treatment against tremor and Parkinson’s Disease. More recent research indicates that deep brain stimulation may also inhibit epileptic seizures. We have therefore studied the effect and security of such treatment.

18 people with treatment refractory epilepsy were implanted with electrodes for deep brain stimulation. Stimulation was started immediately after the operation in one half of the patients. After six months stimulation was turned on also in the remaining patients. The study was double blinded. Neither the patients nor the treating neurologist knew which patients where on active stimulation during the first six months.

We found no significant differences between the two groups after six months. After six months of active stimulation also in the second group, we found that all 18 patients had a significant 22% improvement in seizure frequency after six months of deep brain stimulation.

We originally planned to include 40 patients. Study inclusion was stopped prematurely since a halfway analysis revealed that results were not as good as expected.

The study showed a moderately improved seizure frequency. The operation procedure and deep brain stimulation were well tolerated. Higher mental functions like language, memory and executive functions were not affected, and we found no psychiatric adverse effects like anxiety or depression.

We performed an extra study method review since our results were not as good as expected. A slightly different procedure for placing the electrodes will probably improve accuracy and help finding the best target for deep brain stimulation in epilepsy.

More and larger studies are needed to decide the place for deep brain stimulation in the treatment of epilepsy in Norway.

Additional information

Contact the research support staff.

Published Aug. 15, 2024 11:04 AM - Last modified Aug. 15, 2024 11:09 AM